Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

SurvivorLink: Scalability of an Electronic Personal Health Record

ClinicalTrials.gov ID: NCT03543852

Public ClinicalTrials.gov record NCT03543852. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SurvivorLink: Scalability of an Electronic Personal Health Record for Cancer Survivors and Caregivers at Pediatric Cancer Centers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Previous research suggests that children and adolescents with cancer are at heightened risk of late effects that can occur months or years after cancer treatment, yet little is known about programs that increase their return for follow-up cancer care and late effects surveillance. This study will evaluate the impact of an electronic personal health record and education system, SurvivorLink, for pediatric cancer survivors and their caregivers. The researchers will develop a standardized intervention and training for the SurvivorLink trial, followed by conducting a Hybrid Type 1 effectiveness-implementation, clustered randomized, waitlist control trial to evaluate the impact of SurvivorLink on pediatric cancer patients' one year follow-up visits and completion of screening tests. The study will also assess the impact of SurvivorLink on caregiver's patient activation, survivor's and caregiver's quality of life, and self-efficacy to manage a chronic condition. This study will provide the evidence base about the effects of the system to improve follow-up care for children and adolescents with cancer and best practices for implementation for pediatric cancer centers.

Study identification

NCT ID
NCT03543852
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Emory University
Other
Enrollment
580 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
15 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 13, 2021
Primary completion
Dec 14, 2024
Completion
Dec 24, 2024
Last update posted
Feb 24, 2025

2021 – 2024

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Banner University Medical Center in Tucson Tucson Arizona 85719
Children's Hospital of Orange County Orange California 92868
Children's National Medical Center Washington D.C. District of Columbia 20010
Arnold Palmer Hospital for Children Orlando Florida 32806
University of Chicago Medicine Comer Children's Hospital Chicago Illinois 60637
Riley Children's Health Indianapolis Indiana 46202
University of Iowa Stead Family Children's Hospital Iowa City Iowa 52242
Washington University St. Louis Children's Hospital St Louis Missouri 63110
Upstate Medical University Syracuse New York 13210
Penn State Children's Hospital Hershey Pennsylvania 17033
University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03543852, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03543852 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →